Twist Bioscience (TWST) Cash from Investing Activities (2017 - 2026)
Twist Bioscience (TWST) has 10 years of Cash from Investing Activities data on record, last reported at -$12.7 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 791.02% to -$12.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$44.4 million, a 796.31% decrease, with the full-year FY2025 number at -$24.8 million, down 706.32% from a year prior.
- Cash from Investing Activities reached -$12.7 million in Q1 2026 per TWST's latest filing, down from -$9.9 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for TWST hit a ceiling of $41.2 million in Q1 2023 and a floor of -$13.3 million in Q1 2022.
- A 5-year average of -$365176.5 and a median of -$1.5 million in 2024 define the central range for Cash from Investing Activities.
- Peak YoY movement for Cash from Investing Activities: surged 409.61% in 2023, then plummeted 1221.66% in 2025.
- Tracing TWST's Cash from Investing Activities over 5 years: stood at -$7.0 million in 2022, then skyrocketed by 159.75% to $4.2 million in 2023, then plummeted by 136.88% to -$1.5 million in 2024, then crashed by 546.68% to -$9.9 million in 2025, then dropped by 27.92% to -$12.7 million in 2026.
- Business Quant data shows Cash from Investing Activities for TWST at -$12.7 million in Q1 2026, -$9.9 million in Q4 2025, and -$12.4 million in Q3 2025.